Infective endocarditis developing early after percutaneous closure of a patent ductus arteriosus in a child using the Amplatzer Duct Occluder II

Cardiol Young. 2020 Apr;30(4):591-593. doi: 10.1017/S1047951120000542. Epub 2020 Mar 19.

Abstract

A 10-month-old girl underwent patent ductus arteriosus closure with an Amplatzer Duct Occluder II. After 1 week, she was admitted to our emergency room with tachypnoea, fatigue, and fever. Consecutive blood cultures yielded vancomycin-sensitive Staphylococcus aureus. The patient was already receiving vancomycin, but the fever did not respond to this treatment. The device was successfully removed via left lateral thoracotomy.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cardiac Catheterization / adverse effects*
  • Cardiac Surgical Procedures / adverse effects*
  • Device Removal / methods
  • Ductus Arteriosus, Patent / surgery*
  • Echocardiography
  • Endocarditis / diagnosis
  • Endocarditis / etiology*
  • Endocarditis / therapy
  • Female
  • Humans
  • Infant
  • Postoperative Complications*
  • Septal Occluder Device*

Substances

  • Anti-Bacterial Agents